Soumit Roy
Stock Analyst at Jones Trading
(1.60)
# 3,285
Out of 4,944 analysts
42
Total ratings
21.88%
Success rate
-4.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics | Initiates: Buy | $21 | $3.07 | +584.04% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $16.94 | +136.13% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $18.83 | +43.39% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.25 | - | 2 | May 16, 2025 | |
| ONCY Oncolytics Biotech | Downgrades: Hold | n/a | $0.86 | - | 2 | May 16, 2025 | |
| MURA Mural Oncology | Downgrades: Hold | n/a | $1.66 | - | 2 | Mar 25, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $15 | $9.40 | +59.57% | 3 | Mar 13, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $2.32 | +331.03% | 1 | Mar 12, 2025 | |
| BEAM Beam Therapeutics | Upgrades: Buy | $34 | $16.86 | +101.66% | 2 | Mar 10, 2025 | |
| INAB IN8bio | Upgrades: Buy | $36 | $2.25 | +1,500.00% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.00 | +1,500.00% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.92 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $9.40 | -4.26% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $9.52 | +78.57% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.29 | +467.69% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.64 | +525.98% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.32 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.50 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $7.29 | +256.90% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $24.27 | +188.42% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $35.90 | -72.14% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.47 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $11.10 | +620.72% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.75 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $4.48 | +7,042.86% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.38 | +18,393.15% | 1 | Feb 24, 2021 |
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $3.07
Upside: +584.04%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $16.94
Upside: +136.13%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $18.83
Upside: +43.39%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.25
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.86
Upside: -
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.66
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $9.40
Upside: +59.57%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $2.32
Upside: +331.03%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $16.86
Upside: +101.66%
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $2.25
Upside: +1,500.00%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.00
Upside: +1,500.00%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.92
Upside: -
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $9.40
Upside: -4.26%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $9.52
Upside: +78.57%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.29
Upside: +467.69%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.64
Upside: +525.98%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.32
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.50
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $7.29
Upside: +256.90%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $24.27
Upside: +188.42%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $35.90
Upside: -72.14%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.47
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $11.10
Upside: +620.72%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.75
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $4.48
Upside: +7,042.86%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.38
Upside: +18,393.15%